BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31093793)

  • 21. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
    Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
    Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAGE-A3 is a frequent tumor antigen of metastasized melanoma.
    Roeder C; Schuler-Thurner B; Berchtold S; Vieth G; Driesch Pv; Schuler G; Lüftl M
    Arch Dermatol Res; 2005 Jan; 296(7):314-9. PubMed ID: 15570431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.
    Sang M; Gu L; Liu F; Lian Y; Yin D; Fan X; Ding C; Huang W; Liu S; Shan B
    Arch Med Res; 2016 Apr; 47(3):151-61. PubMed ID: 27362547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral brush biopsy and melanoma-associated antigens A (MAGE-A) staining in clinically suspicious lesions.
    Hartmann S; Kipke RU; Rauthe S; Mutzbauer G; Brands RC; Ebhardt H; Kübler AC; Müller-Richter UD
    J Craniomaxillofac Surg; 2015 Dec; 43(10):2214-8. PubMed ID: 26589180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
    Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
    Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
    Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
    Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different expression of MAGE-A-antigens in foetal and adult keratinocyte cell lines.
    Müller-Richter UD; Dowejko A; Zhou W; Reichert TE; Driemel O
    Oral Oncol; 2008 Jul; 44(7):628-33. PubMed ID: 17993289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
    Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
    Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of MAGE A1 in oral squamous cell carcinoma.
    Pereira CM; Gomes CC; De Fátima Correia Silva J; Bucciarelli Rodriguez M; Barbosa AA; Gomez RS
    Oncol Rep; 2012 Jun; 27(6):1843-8. PubMed ID: 22447174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
    Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
    Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of family A melanoma antigen in human gastric carcinoma.
    Jung EJ; Kim MA; Lee HS; Yang HK; Lee YM; Lee BL; Kim WH
    Anticancer Res; 2005; 25(3B):2105-11. PubMed ID: 16158951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
    Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.
    Sarcevic B; Spagnoli GC; Terracciano L; Schultz-Thater E; Heberer M; Gamulin M; Krajina Z; Oresic T; Separovic R; Juretic A
    Oncology; 2003; 64(4):443-9. PubMed ID: 12759544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
    Han L; Jiang B; Wu H; Zhang S; Lu X
    Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
    Pan SH; Su KY; Spiessens B; Kusuma N; Delahaye NF; Gruselle O; Myo A; de Creus A; Louahed J; Chang GC; Yu SL; Yang PC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e212-e223. PubMed ID: 27519286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
    Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.